1.15
price up icon0.88%   +0.01
after-market  Handel nachbörslich:  1.15 
loading

Akebia Therapeutics Inc. Aktie (AKBA) Neueste Nachrichten

Analyzing Atea Pharmaceuticals (NASDAQ:AVIR) & Akebia Therapeutics (NASDAQ:AKBA) - Defense World

pulisher
Defense World

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Short Interest Down 13.4% in April - Defense World

pulisher
Defense World

Will Akebia Therapeutics (AKBA) Report Negative Earnings Next Week? What You Should Know - Yahoo New Zealand News

pulisher
Yahoo New Zealand News

Akebia Therapeutics executive sells $15,140 in company stock By Investing.com - Investing.com Canada

pulisher
Investing.com Canada

Akebia Therapeutics COO Michel Dahan sells $43.9k in stock - Investing.com Australia

pulisher
Investing.com Australia

Akebia Therapeutics executive sells $15,140 in company stock By Investing.com - Investing.com

pulisher
Investing.com

Akebia Therapeutics COO Michel Dahan sells $43.9k in stock - Investing.com India

pulisher
Investing.com India

Akebia Therapeutics COO Michel Dahan sells $43.9k in stock - Investing.com South Africa

pulisher
Investing.com South Africa

Akebia Therapeutics COO Michel Dahan sells $43.9k in stock - Investing.com Canada

pulisher
Investing.com Canada

Akebia Therapeutics COO Michel Dahan sells $43.9k in stock - Investing.com

pulisher
Investing.com

Akebia Therapeutics executive sells $15,140 in company stock By Investing.com - Investing.com UK

pulisher
Investing.com UK

Akebia Therapeutics COO Michel Dahan sells $43.9k in stock By Investing.com - Investing.com UK

pulisher
Investing.com UK

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Short Interest Update - MarketBeat

pulisher
MarketBeat

Akebia Therapeutics to Present at the 2nd Annual HCW Bioconnect Investor Conference - Citizentribune

pulisher
Citizentribune

Akebia Therapeutics to Present at the 2nd Annual HCW Bioconnect Investor Conference - Investing.com India

pulisher
Investing.com India

Akebia Therapeutics to Present at the 2nd Annual HCW Bioconnect Investor Conference - PR Newswire

pulisher
PR Newswire

Akebia Therapeutics to Present at the 2nd Annual HCW Bioconnect Investor Conference - Investing.com South Africa

pulisher
Investing.com South Africa

Should You Worry About Akebia Therapeutics, Inc.'s (NASDAQ:AKBA) CEO Pay Cheque? - Yahoo News UK

pulisher
Yahoo News UK

Do Options Traders Know Something About Akebia (AKBA) Stock We Don't? - Yahoo News Australia

pulisher
Yahoo News Australia

Should You Worry About Akebia Therapeutics, Inc.'s (NASDAQ:AKBA) CEO Pay Cheque? - Yahoo News UK

pulisher
Yahoo News UK

Revenue Downgrade: Here's What Analysts Forecast For Akebia Therapeutics, Inc. (NASDAQ:AKBA) - Yahoo Finance

pulisher
Yahoo Finance

Akebia Therapeutics (NASDAQ:AKBA) Issues Earnings Results - MarketBeat

pulisher
MarketBeat

Akebia Therapeutics Reports Q1 2024 Financial Results: A Detailed Overview - Yahoo Finance

pulisher
Yahoo Finance

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q1 2024 Earnings Call Transcript - Yahoo Finance

pulisher
Yahoo Finance

Akebia Therapeutics First Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

pulisher
Yahoo Finance

Akebia Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights - The Malaysian Reserve

pulisher
The Malaysian Reserve

Akebia Therapeutics Reports Q1 2024 Financial Results: A Detailed Overview - Yahoo Finance

pulisher
Yahoo Finance

Akebia Therapeutics executive sells shares worth over $31,000 By Investing.com - Investing.com Australia

pulisher
Investing.com Australia

Akebia Therapeutics executive sells shares worth over $31,000 - Investing.com ZA - Investing.com South Africa

pulisher
Investing.com South Africa

Akebia Therapeutics executive sells shares worth over $31,000 By Investing.com - Investing.com

pulisher
Investing.com

Akebia Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights - citybiz

pulisher
citybiz

Akebia Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights - Citizentribune

pulisher
Citizentribune

Akebia Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights - Investing.com India

pulisher
Investing.com India

Akebia Therapeutics (AKBA) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Canada Finance

pulisher
Yahoo Canada Finance

Akebia Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights - PR Newswire

pulisher
PR Newswire

Akebia Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights - Citizentribune

pulisher
Citizentribune

Akebia Therapeutics (AKBA) Scheduled to Post Earnings on Thursday - Defense World

pulisher
Defense World

Are Options Traders Betting on a Big Move in Akebia (AKBA) Stock? - Yahoo Canada Shine On

pulisher
Yahoo Canada Shine On

Implied Volatility Surging for Akebia Therapeutics (AKBA) Stock Options - Yahoo Singapore News

pulisher
Yahoo Singapore News

Akebia Therapeutics (AKBA) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Movies Canada

pulisher
Yahoo Movies Canada

Akebia Therapeutics (AKBA) Scheduled to Post Earnings on Thursday - MarketBeat

pulisher
MarketBeat

Akebia Therapeutics to Report First Quarter 2024 Financial Results and Discuss Recent Business Highlights - Yahoo Finance

pulisher
Yahoo Finance

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PR Newswire

pulisher
PR Newswire

Akebia Therapeutics (NASDAQ:AKBA) Lowered to “Hold” at StockNews.com - Defense World

pulisher
Defense World

When Can We Expect A Profit From Akebia Therapeutics, Inc. (NASDAQ:AKBA)? - Yahoo Finance

pulisher
Yahoo Finance

Buy Vafseo's Approval: A New Chapter For Akebia Therapeutics In Anemia Management (AKBA) - Seeking Alpha

pulisher
Seeking Alpha

Akebia Therapeutics (NASDAQ:AKBA) Upgraded by StockNews.com to "Buy" - MarketBeat

pulisher
MarketBeat

Akebia's Vafseo Faces Grim Market Outlook (Rating Downgrade) (NASDAQ:AKBA) - Seeking Alpha

pulisher
Seeking Alpha

Akebia Recovers From Rejection to Win FDA Approval for Anemia Drug - MedCity News

pulisher
MedCity News

Why RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket

pulisher
Benzinga
$77.56
price up icon 0.77%
$149.40
price down icon 1.20%
$29.98
price up icon 1.11%
$172.85
price up icon 1.06%
$365.81
price down icon 2.87%
$90.61
price down icon 2.55%
Kapitalisierung:     |  Volumen (24h):